Korea Pharmaceutical Bio Association opens training on digital conversion of pharmaceuticals and computer system guarantee
Oct 20, 2025
|
The training, which will be held at the association hall in Bangbae-dong, Seoul, from October 28 to 29, is designed to strengthen on-site practical capabilities to actively respond to changes in the regulatory environment at home and abroad under the theme of applying digital conversion (DX) and computer system guarantee (CSA).
Students will learn the concept of ▲ GMP digital transformation and domestic and international regulatory trends ▲ changes from computer system validation (CSV) to CSA and key concepts ▲ GMP manufacturing and quality management application cases using digital technology ▲ strategies for responding to due diligence by global regulators. Through this, it is expected to be able to understand a wide range of basic theories to practical application cases and secure practical capabilities that can be used in the field.
This course is aimed at practitioners preparing for digital innovation, such as IT, CSV, and DX strategic planners, as well as pharmaceutical and bio manufacturing and quality managers, and is operated in an offline collective education method. The purpose is to increase the concentration of field-oriented communication and education.
Training is available for both member and non-member companies, and applications for classes are received on a first-come, first-served basis through the association's education center website.
Chang Woo-soon, president of the association's Pharmaceutical and BioAcademy, said, `Digital transformation and CSA regulatory response are essential tasks in the pharmaceutical and bio industries.' Through this training, we will actively support member companies to respond preemptively to regulatory changes and strengthen their practical capabilities" he said.
This article was translated by Naver AI translator.
